Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro.
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
[Multiple Sclerosis and Commensal Gut Flora].
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
What is the future of proof of concept studies in multiple sclerosis?
Conformational changes associated with L16P and T118M mutations in the membrane embedded PMP22 protein, consequential in CMT-1A.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
Neurorehabilitation: applied neuroplasticity.
Back Cover: Eur. J. Immunol. 7'16.
Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
Hereditary and metabolic myelopathies.
No association of tobacco use and disease activity in multiple sclerosis.
Regional differences in interhemispheric structural fibers in healthy, term infants.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Individuals with multiple sclerosis redistribute positive mechanical work from the ankle to the hip during walking.
Pediatric multiple sclerosis: Perspectives from adolescents and their families.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Pages
« first
‹ previous
…
740
741
742
743
744
745
746
747
748
…
next ›
last »